Ex-vivo Lung Perfusion and Its Role in Experimental Studies
Lung transplantation is an accepted treatment modality for end-stage lung diseases. However, the donor pool is not getting larger in comparison to the number of patients on the waiting list. Of the patients on the waiting list for lung transplant, more than a quarter dies while waiting. Utilization...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-08-01
|
Series: | Eurasian Journal of Pulmonology |
Subjects: | |
Online Access: | http://www.eurasianjpulmonol.com/jvi.aspx?pdir=eurasianjpulmonol&plng=eng&un=EJP-44366 |
id |
doaj-b3ed105457e04139b52750d51d7d07a4 |
---|---|
record_format |
Article |
spelling |
doaj-b3ed105457e04139b52750d51d7d07a42020-11-25T00:38:32ZengWolters Kluwer Medknow PublicationsEurasian Journal of Pulmonology 2148-54022017-08-01192657010.5152/ejp.2017.44366Ex-vivo Lung Perfusion and Its Role in Experimental StudiesTuğba Coşgun0Gül Dabak1Ömer Şenbaklavacı2Department of Thoracic Surgery, Acıbadem University Atakent Hospital, İstanbul, TurkeyDepartment of Chest Diseases, Acıbadem University Atakent Hospital, İstanbul, TurkeyDepartment of Thoracic Surgery, Acıbadem University Atakent Hospital, İstanbul, TurkeyLung transplantation is an accepted treatment modality for end-stage lung diseases. However, the donor pool is not getting larger in comparison to the number of patients on the waiting list. Of the patients on the waiting list for lung transplant, more than a quarter dies while waiting. Utilization of marginal donors became an issue, and ex-vivo lung perfusion (EVLP) was started to be performed to solve this problem. Besides that, success in lung transplantation has not reached a satisfactory level for various reasons including ischemia reperfusion injury. Treatment options against these reasons that cause low success of lung transplantations are being investigated by many centers. Nowadays, EVLP that was initially developed to re-evaluate marginal donors has become a method for studies in experimental models. In our article, we want to review EVLP models in experimental studies.http://www.eurasianjpulmonol.com/jvi.aspx?pdir=eurasianjpulmonol&plng=eng&un=EJP-44366Ex-vivo lung perfusionEx-vivo lung perfusiolung transplantation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tuğba Coşgun Gül Dabak Ömer Şenbaklavacı |
spellingShingle |
Tuğba Coşgun Gül Dabak Ömer Şenbaklavacı Ex-vivo Lung Perfusion and Its Role in Experimental Studies Eurasian Journal of Pulmonology Ex-vivo lung perfusion Ex-vivo lung perfusio lung transplantation |
author_facet |
Tuğba Coşgun Gül Dabak Ömer Şenbaklavacı |
author_sort |
Tuğba Coşgun |
title |
Ex-vivo Lung Perfusion and Its Role in Experimental Studies |
title_short |
Ex-vivo Lung Perfusion and Its Role in Experimental Studies |
title_full |
Ex-vivo Lung Perfusion and Its Role in Experimental Studies |
title_fullStr |
Ex-vivo Lung Perfusion and Its Role in Experimental Studies |
title_full_unstemmed |
Ex-vivo Lung Perfusion and Its Role in Experimental Studies |
title_sort |
ex-vivo lung perfusion and its role in experimental studies |
publisher |
Wolters Kluwer Medknow Publications |
series |
Eurasian Journal of Pulmonology |
issn |
2148-5402 |
publishDate |
2017-08-01 |
description |
Lung transplantation is an accepted treatment modality for end-stage lung diseases. However, the donor pool is not getting larger in comparison to the number of patients on the waiting list. Of the patients on the waiting list for lung transplant, more than a quarter dies while waiting. Utilization of marginal donors became an issue, and ex-vivo lung perfusion (EVLP) was started to be performed to solve this problem. Besides that, success in lung transplantation has not reached a satisfactory level for various reasons including ischemia reperfusion injury. Treatment options against these reasons that cause low success of lung transplantations are being investigated by many centers. Nowadays, EVLP that was initially developed to re-evaluate marginal donors has become a method for studies in experimental models. In our article, we want to review EVLP models in experimental studies. |
topic |
Ex-vivo lung perfusion Ex-vivo lung perfusio lung transplantation |
url |
http://www.eurasianjpulmonol.com/jvi.aspx?pdir=eurasianjpulmonol&plng=eng&un=EJP-44366 |
work_keys_str_mv |
AT tugbacosgun exvivolungperfusionanditsroleinexperimentalstudies AT guldabak exvivolungperfusionanditsroleinexperimentalstudies AT omersenbaklavacı exvivolungperfusionanditsroleinexperimentalstudies |
_version_ |
1725296984549490688 |